AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01759979 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Lithotripsy
Description: Patients in the mechanical lithotripsy arm will undergo treatment only with basket and balloons to facilitate stone removal but not laser lithotripsy.
Study NCT03401788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 120 mg once daily (three 40 mg oral tablets once daily).
Study NCT02135809 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WallFlex Pancreatic Stent
Description: Temporary placement of the WallFlex Pancreatic Stent for treatment of refractory pancreatic duct strictures in patients with painful chronic pancreatitis. Stent will be removed after 3-6 months indwell.
Study NCT03493685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sparsentan
Description: Double-blind period: target dose of 800 mg daily; Open-label extension: target dose based on dosage from week 114 daily
Study NCT03493685 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irbesartan
Description: target dose of 300 mg daily
Study NCT02513641 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypoxico Altitude Training Systems
Description: Participants will sleep in a tent (which will fit his/her personal mattress) simulating an altitude of \~2,400 meters for 7-12 hours each night for a period of 14 days. Baseline testing measures will include a oral glucose tolerance test (OGTT) and body composition (iDXA). Post-treatment testing measures will include OGTT only.
Study NCT03035214 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dexamethasone (Steroids)
Description: Is to describe the use of integrated assessment of respiratory physiology using Targeted Neonatal Echocardiography, assessment of optimal Functional Residual Capacity and the tolerance of lung oxygen uptake at different oxygen levels, and hence early prediction of Bronchopulmonary Dysplasia and the underlying pathophysiology by periodic application of the oxygen tolerance test; which may help early targeted treatment of this common disease.
Study NCT00153205 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: computerized physician order entry
Study NCT00153205 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: computerized physician order entry
Study NCT00569777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: K-Lens (generic name not established) and Ketotifen
Description: combination drug-device product: contact lens (device) and anti-allergy drug
Study NCT00569777 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Lens
Description: contact lens without drug
Study NCT03304782 — intervention group
Intervention type: OTHER
Intervention: Fitbit activity tracker
Description: Wearable device that records the number of steps a person takes throughout the day
Study NCT00004241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tanespimycin
Description: Given IV
Study NCT00004241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT03656263 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Doppler assessment of portal vein flow
Description: Doppler assessment of portal vein flow using peri-operative trans-esophageal echography before and after cardiopulmonary bypass.
Study NCT01853371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wet cupping
Description: Wet cupping is the process of using a vacuum at different points on the body in order to gather the blood in that area. Then apply few superficial incisions (small, light scratches using a razor) on those areas, followed by repeating the vacuum on the same areas in order to remove 'harmful' blood which lies just beneath the surface of the skin. In this study, the wet cupping procedure was not done on certain days of the lunar month.
Study NCT01853371 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: According to Saudi Hypertension management guidelines, hypertension patients may require life style modification alone , especially for newly diagnosed cases, or my require life style modification and drug treatment. This will be decided by the treating team in the hospital.
Study NCT01853371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment
Description: According to Saudi Hypertension management guidelines, hypertension patients may require life style modification alone , especially for newly diagnosed cases, or my require life style modification and drug treatment. This will be decided by the treating team in the hospital.
Study NCT01616316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: subfascial flap
Description: subfacial dissection to thyroid
Study NCT01616316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: subplatysmal flap
Description: subplatysmal approach to thyroid
Study NCT04615312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: a CDK4 / 6 inhibitor and a MEK inhibitor
Description: Participant will receive a CDK4 / 6 inhibitor and a MEK inhibitor treatment to determine the maximum tolerated dose
Study NCT02798003 — intervention group
Intervention type: OTHER
Intervention: Functional magnetic resonance imaging (fMRI)
Description: The food-cue elicited response in the reward-circuitry of the brain will be assessed by using fMRI. This technique is based on different magnetic properties of oxygenated and deoxygenated blood. Increased neuronal activity causes an increase in blood flow. Thereby, neuronal activity is indirectly reflected by changes in blood oxygenation level-dependent (BOLD) contrast.
Study NCT00657683 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Monovalent GBS-CRM glycoconjugate vaccine
Description: 1 dose of GBS conjugate vaccine
Study NCT00657683 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 dose of placebo
Study NCT02235688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 170 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.
Study NCT02235688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 250 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.
Study NCT02235688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 350 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.
Study NCT02235688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Study NCT03557905 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RM 0.5
Description: Patients will receive recruitment maneuver (RM) followed by decremental PEEP titration 1min. after establishment of mechanical ventilation and after documented lung re-collapse.
Study NCT03557905 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RM 0.3
Description: The patient will be ventilated with volume control mode with tidal volume 6 ml/kg, PEEP 3 cmH2O, an inspiratory expiratory ratio of 1:1.5, respiratory rate 20-25 breaths per minute depending on the patient's age and FiO2 of 0.3.
Study NCT00131885 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control (Placebo Herb)
Description: Placebo herb three times daily (ground cellulose) for 4-6 weeks
Study NCT00131885 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: St. John's Wort
Description: St. John's Wort (Hypericum perforatum) orally or 4-6 weeks
Study NCT00131885 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose
Study NCT00131885 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose
Study NCT03186820 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Susceptibility Weighted Imaging as 3D SWAN sequence
Description: Susceptibility Weighted Imaging as 3D SWAN sequence
Study NCT03334955 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling
Description: A specially designed monopolar electrocautery probe was used to penetrate the ovarian capsule at 4 points, with the aid of a short burst of monopolar diathermy. The probe (which has a distal stainless steel needle measuring 10 mm in length and 2 mm in diameter) was applied to the surface of the ovary at a right angle to avoid slippage and to minimize surface damage. A monopolar coagulating current at a 40 W power setting was used. The needle was pushed through the ovarian capsule for about 4 mm depth into the ovarian tissue and electricity was activated for 4 seconds.
Study NCT03734055 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Mentoring
Description: Manualized peer mentorship program designed to provide modeling and reinforcement by peers (mentors) to other African American women with SLE (mentees) to encourage them to engage in activities that promote disease self-management.
Study NCT03734055 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Support Group
Description: Social support controls will participate in a lupus support group created for this project, on the same schedule as peer mentoring sessions.
Study NCT02614248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Organic, Unrefined Coconut Oil
Study NCT03889093 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Yttrium-90
Description: This is to evaluate the immunologic effects of yttrium 90.
Study NCT01925001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MP4CO
Description: 43 mg/mL pegylated carboxyhemoglobin \[≥ 90% CO hemoglobin saturation\] in physiological acetate electrolyte solution
Study NCT02614248 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medline Remedy Phytoplex Z-Guard Skin Protectant
Study NCT01586910 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Study NCT01586910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)
Study NCT01586910 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
Study NCT04473196 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: weightbearing
Description: immediate weightbearing
Study NCT04280783 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Physical Activity for The Heart (PATH) intervention
Description: The web-based Physical Activity for The Heart (PATH) intervention leverages openly accessible platforms, such as YouTube, to proffer workout videos that match the participants preferences. Currently, PATH includes over 90 workout videos vetted by a team of experts and curated on the PATH website in 3 controlled levels of intensity (beginner, intermediate, proficient) to foster gradual progression from low to high intensity PA in accordance with the FITT-VP (frequency, intensity, time, type, volume, progression) principle.
Study NCT04280783 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Be Active Your Way Booklet
Description: Be Active Your Way booklet was developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives. It simply encourages individuals to increase their PA gradually and gives them examples of things that they can do.
Study NCT03443401 — intervention group
Intervention type: PROCEDURE
Intervention: Standard physical therapy care
Description: standard plan of care delivered to patient with chronic low back within scope of licensure
Study NCT00800345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Topotecan
Description: Starting on Cycle 1 Day 1, each subject will receive the assigned dose of topotecan administered by mouth.
Study NCT00800345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Starting on Cycle 1 Day 1, each subject will receive the assigned dose of pazopanib administered by mouth.
Study NCT03457662 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: OMC and pseudo-SDT
Description: OMC is established according to the 2016 ACC-AHA Guidelines for the Management of Patients with PAD. Pseudo-SDT combines saline injection and obstructed ultrasound exposure on targeted lesions to simulate real SDT progression.
Study NCT06464874 — intervention group
Intervention type: PROCEDURE
Intervention: Conventional ESD
Description: Conventional ESD is the most suitable method for total resection, especially for large lesions. This method can complete the resection of early gastrointestinal cancer and precancerous lesions, while maintaining the integrity of digestive tract anatomy and physiological function.The operation difficulty of this technique is high, the equipment requirements are high, the operation time is long, and the complication rate is closely related to the technical level of the operator.
Study NCT00332878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepping Stones
Description: a comprehensive sexual and reproductive health promotion programme lasting about 50 hours comprising 13 content sessions of about 3 hours duration and 4 meetings of peer groups
Study NCT00332878 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: stepping Stones short
Description: 3 hour intervention on HIV and safer sex
Study NCT03585842 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT01925001 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium chloride solution
Description: Normal saline solution (0.9% Sodium Chloride Injection USP)
Study NCT06464874 — intervention group
Intervention type: PROCEDURE
Intervention: Hybrid ESD
Description: Hybrid ESD is a better choice, but only can remove the lesion in one piece, but also has a lower technical difficulty than conventional ESD
Study NCT05830682 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: using a walking aid
Description: The walking aid utilized for mobilizing patients in the intervention group during the study is a four-wheeled device that allows for movement in all directions. The height of the device can be adjusted according to the patients' height. It features a seat for resting when needed and a braking system that is controlled from the hand grips.
Study NCT01817686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comfort Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.
Study NCT01817686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Life Extension Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.
Study NCT01817686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.
Study NCT02971813 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Facebook
Description: 1. Volunteers will be recruited during inpatient stay, or via phone call or in person after discharge and prior to beginning cardiac rehabilitation.~2. Participants will be given a baseline BREQ-3 survey and a PNSE scale.~3. Patients will be randomized to Facebook™ versus comparison groups using a blocked randomization.~4. The Facebook™ intervention will include peer support, education, provider support and text message prompts when new posts are added.~   1. Educational posts will cover topics that will cover healthcare information.~  2. Provider support will be posted much like the educational posts.~5. The data collection for this study will take place prior to beginning cardiac rehabilitation, at which time the participants will receive the BREQ-3 and PNSE surveys either in person or via email link.~6. Post-testing will include a BREQ-3 and PNSE surveys and count of the number of sessions completed in a 3 month period of time.
Study NCT02971813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facebook
Description: 1. Volunteers will be recruited during inpatient stay, or via phone call or in person after discharge and prior to beginning cardiac rehabilitation.~2. Participants will be given a baseline BREQ-3 survey and a PNSE scale.~3. Patients will be randomized to Facebook™ versus comparison groups using a blocked randomization.~4. The Facebook™ intervention will include peer support, education, provider support and text message prompts when new posts are added.~   1. Educational posts will cover topics that will cover healthcare information.~  2. Provider support will be posted much like the educational posts.~5. The data collection for this study will take place prior to beginning cardiac rehabilitation, at which time the participants will receive the BREQ-3 and PNSE surveys either in person or via email link.~6. Post-testing will include a BREQ-3 and PNSE surveys and count of the number of sessions completed in a 3 month period of time.
Study NCT01466036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: 60 mg QD orally in cycles of 28 days
Study NCT03799822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 MG Oral Tablet
Description: replacement of warfarin by rivaroxaban
Study NCT03799822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MK-7 2000µg thrice weekly
Description: dietary supplement of vitamin K2 MK-7 2000µg thrice weekly
Study NCT03799822 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin K Antagonist - Drug
Description: treatment with a vitamin K antagonist
Study NCT01480895 — intervention group
Intervention type: BEHAVIORAL
Group type: NO_INTERVENTION
Intervention: Lifestyle instruction for Jews and Bedouin GDM women.
Description: Every several months the women had instructions and checkups.
Study NCT01480895 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle instruction for Jews and Bedouin GDM women.
Description: Every several months the women had instructions and checkups.
Study NCT05995990 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Raman Spectrometry
Description: Laboratory technique of Raman Spectrometry
Study NCT04339595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tildrakizumab
Description: Participants who have participated and completed the long-term extension phase of the reSURFACE 2 study (NCT01729754) and 12 weeks after the last Tildrakizumab dose will be included in the present study. Participants will not receive any study medication during the present study. Participants will remain in the study for 96 weeks or until they initiate any systemic therapy for psoriasis (including phototherapy), whichever occurs first.
Study NCT02962089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Branched chain amino acids (BCAA)
Study NCT02962089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01358396 — intervention group
Intervention type: OTHER
Intervention: Respond to therapy for diabetic macular edema
Description: Correlate HBA1c with visual acuity outcome to therapy.
Study NCT00152906 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) or highly conformal (CRT)
Description: SRT or CRT is radiation delivered precisely conforming the high dose region to the tumor, usually in a few highdose fractions.
Study NCT02361957 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ecologic 825
Description: Multispecies probiotic product, 2.5 x10E9 colony forming units per gram, 6 grams a day
Study NCT04010032 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus
Description: bolus administration of 0.15 ml of ropivacaine 0.15 ml / kg into epidural space every hour(intermittent bolus injection) using PCA device
Study NCT04010032 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous epidural infusion
Description: Continuous infusion of 0.15% ropivacaine 0.15 ml / kg / h into the epidural space using PCA device using PCA device